No Detail Found!

Frequency of Dyslipidemia in Patients of Type 2 Diabetes with Hypertension in Southern Punjab Tertiary Care Hospital.

Author(s)
Asad Raza Central Ammunition Depot Sargodha, Pakistan
Mutahir Abbas Virk Combined Military Hospital Khuzdar, Pakistan
Asif Yasin Combined Military Hospital Multan, Pakistan
Rizwan Azam Combined Military Hospital Loralai Pakistan
Abstract
Objective: To determine the frequency of dyslipidemia in patients of type 2 diabetes with hypertension. Study Design: Cross-sectional study. Place and Duration of Study: Combined Military Hospital Multan, from Jun 2014 to Dec 2014. Material and Methods: A total of 145 diagnosed patients of diabetes mellitus aged >35 years, were included through non-probability consecutive sampling. Dyslipidemia was defined on the basis of laboratory report of fasting lipid profile with serum cholesterol >180 mg/dl, serum triglyceride >150 mg/dl and HDL 180mg/dl in 83 (57.2%) patients. Serum triglyceride was found to be >150 mg/dl in 102 (70.34%) patients. HDL was found to be low in 116, 145 mg/dl (80%) patients. Mean for total cholesterol level was 202.03 ± 39.24 mg/dl. Mean triglyceride level was 188.85 ± 48.98 mg/dl. Mean HDL level was 38.82 ± 8.32 mg/dl. Hyperlipidemia was found to be present in 117 (80.7%) of the patients. There was no significant effect of age, gender, duration of diabetes, duration of hypertension, BMI and number of smoking pack years on the frequency of dyslipidemia. Conclusion: Patients with type 2 diabetes mellitus and hypertension are at a high risk of having dyslipidemia and the most frequently identified lipid abnormality in these patients is a low HDL level.
Publication Details
Page(s) 749-754
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 4, Year: 2018

Request the full text from PASTIC

References
JainS,SarafS., 2010.Type 2 diabetes mellitus - Its global prevalence and therapeutic strategies. In: diabetes and metabolic syndrome: Clinical research and reviews,Raipur: Elsevier 48 -56
BarkoudahE,SkaliH,UnoH,SolomonSD,PfefferMA, 2012.Mortality rates in trials of subjects with type 2 diabetes,J Am Heart Assoc 1 8 -15
HalpernA,ManciniCM,MagalhaesMEC,FisbergM,RadominskiR,BertolamiMC, 2010.Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment,Diabetol Metab Syndr 2 55 -
KumarP,ClarkM.,Kumar, 2016.Clark's Clinical Medicine, 1063 -
RosensonRS,BrewerHB,AnsellBJ,BarterP,ChapmanMJ,HeineckeJW, 2016.Dysfunctional hdl and atherosclerotic cardiovascular disease,Nat Rev Cardiol 13 48 -60
SchultzAB,ChenCY,BurtonWN,EdingtonDW, 2012.The burden and management of dyslipidemia: Practical issues,Popul Health Manag 15 302 -8
MooradianDA, 2009.Dyslipidemia in type 2 diabetes mellitus,Nat Clin Pract Endocrinol Metab 5 150 -9
Liux,Z , Chen,D , Guo,J, 2015.Association of high density lipoprotein with development of metabolic syndrome components: A five year follow-up in adults,BMC Public 15 412 -
GlobalAF,MehtaLJ, 2010.Management of dyslipidemia in the elderly population,Ther Adv Cardiovasc Dis 4 375 -83
PeterS,ChopraS,JacobJJ, 2013.A fish a day, keeps the cardiologist away-A review of the effect of omega-3 fatty acids in the cardiovascular surgery,Indian J Endocrinol Metab 17 422 -9
ShrewastwaMK,ThanpariC,YadavNK,MittalRK,RohilV., 2013.Dyslipidemia in type-2 diabetes mellitus patients in western of Nepal: A Hospital Based Study,Bali Med J 2 44 -
StoneNJ, 2014.ACC/AH A guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of cardiology/American Heart Assoiciation Task Force Practice Guidelines, 129 S1 -
CatapanoAL,GrahamI,De BackerG. 2016, 2016.ESC/EAS Guideleines for the Management of Dyslipidaemias,Eur Heart J 37 2999 -
JacobsonTA,ItoMK,MakiKC,OrringerCE,BaysHE,JonesPH, 2014.National lipid association recommendations for patient centered management of dyslipidemia: Part 1- executive summary,J Clin Lipidol 8 473 -88
0

Citations

0

Downloads

131

Views